92 related articles for article (PubMed ID: 7818819)
1. Increasing age is associated with faster progression to neoplasms but not opportunistic infections in HIV-infected homosexual men.
Veugelers PJ; Strathdee SA; Tindall B; Page KA; Moss AR; Schechter MT; Montaner JS; van Griensven GJ
AIDS; 1994 Oct; 8(10):1471-5. PubMed ID: 7818819
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study.
Rezza G; Dorrucci M; Serraino D; Andreoni M; Giuliani M; Zerboni R; Sarmati L; Colangeli V; Salassa B; Monini P; Ensoli B; Pezzotti P
AIDS; 2000 Jul; 14(11):1647-53. PubMed ID: 10983652
[TBL] [Abstract][Full Text] [Related]
3. Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study.
Veugelers PJ; Page KA; Tindall B; Schechter MT; Moss AR; Winkelstein WW; Cooper DA; Craib KJ; Charlebois E; Coutinho RA
Am J Epidemiol; 1994 Oct; 140(8):747-58. PubMed ID: 7942776
[TBL] [Abstract][Full Text] [Related]
4. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991.
Hessol NA; Koblin BA; van Griensven GJ; Bacchetti P; Liu JY; Stevens CE; Coutinho RA; Buchbinder SP; Katz MH
Am J Epidemiol; 1994 Jun; 139(11):1077-87. PubMed ID: 8192140
[TBL] [Abstract][Full Text] [Related]
5. Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.
Lodi S; Guiguet M; Costagliola D; Fisher M; de Luca A; Porter K;
J Natl Cancer Inst; 2010 Jun; 102(11):784-92. PubMed ID: 20442214
[TBL] [Abstract][Full Text] [Related]
6. Mortality Risk After AIDS-Defining Opportunistic Illness Among HIV-Infected Persons--San Francisco, 1981-2012.
Djawe K; Buchacz K; Hsu L; Chen MJ; Selik RM; Rose C; Williams T; Brooks JT; Schwarcz S
J Infect Dis; 2015 Nov; 212(9):1366-75. PubMed ID: 26044289
[TBL] [Abstract][Full Text] [Related]
7. Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS.
Maas JJ; Dukers N; Krol A; van Ameijden EJ; van Leeuwen R; Roos MT; de Wolf F; Coutinho RA; Keet IP
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):254-9. PubMed ID: 9803967
[TBL] [Abstract][Full Text] [Related]
8. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.
Muñoz A; Schrager LK; Bacellar H; Speizer I; Vermund SH; Detels R; Saah AJ; Kingsley LA; Seminara D; Phair JP
Am J Epidemiol; 1993 Feb; 137(4):423-38. PubMed ID: 8096356
[TBL] [Abstract][Full Text] [Related]
9. Differences in progression to AIDS between injection drug users and homosexual men with documented dates of seroconversion.
Spijkerman IJ; Langendam MW; Veugelers PJ; van Ameijden EJ; Keet IP; Geskus RB; van den Hoek A; Coutinho RA
Epidemiology; 1996 Nov; 7(6):571-7. PubMed ID: 8899381
[TBL] [Abstract][Full Text] [Related]
10. Effect of age at seroconversion on the natural AIDS incubation distribution. Multicenter Hemophilia Cohort Study and the International Registry of Seroconverters.
Rosenberg PS; Goedert JJ; Biggar RJ
AIDS; 1994 Jun; 8(6):803-10. PubMed ID: 8086140
[TBL] [Abstract][Full Text] [Related]
11. Associations of age, immunosuppression, and AIDS among homosexual men in the Tricontinental Seroconverter Study.
Veugelers PJ; Strathdee SA; Kaldor JM; Shafer KA; Moss AR; Schechter MT; Schellekens PT; Coutinho RA; van Griensven GJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Apr; 14(5):435-41. PubMed ID: 9170418
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of medical conditions and symptoms before acquired immunodeficiency syndrome in homosexual and bisexual men infected with the human immunodeficiency virus.
Holmberg SD; Buchbinder SP; Conley LJ; Wong LC; Katz MH; Penley KA; Hershow RC; Judson FN
Am J Epidemiol; 1995 Mar; 141(5):395-404; discussion 405-6. PubMed ID: 7879784
[TBL] [Abstract][Full Text] [Related]
13. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts.
Lifson AR; Hilton JF; Westenhouse JL; Canchola AJ; Samuel MC; Katz MH; Buchbinder SP; Hessol NA; Osmond DH; Shiboski S
AIDS; 1994 Jan; 8(1):73-9. PubMed ID: 8011239
[TBL] [Abstract][Full Text] [Related]
14. Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study.
Prins M; Veugelers PJ
AIDS; 1997 Apr; 11(5):621-31. PubMed ID: 9108944
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma and human herpesvirus 8 infection do not protect HIV-1 infected homosexual men from AIDS dementia complex.
Renwick N; Weverling GJ; Halaby T; Portegies P; Bakker M; Schulz TF; Goudsmit J
AIDS; 2001 Nov; 15(16):2165-9. PubMed ID: 11684936
[TBL] [Abstract][Full Text] [Related]
16. Sexual transmission and the natural history of human herpesvirus 8 infection.
Martin JN; Ganem DE; Osmond DH; Page-Shafer KA; Macrae D; Kedes DH
N Engl J Med; 1998 Apr; 338(14):948-54. PubMed ID: 9521982
[TBL] [Abstract][Full Text] [Related]
17. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study Group.
Pezzotti P; Phillips AN; Dorrucci M; Lepri AC; Galai N; Vlahov D; Rezza G
BMJ; 1996 Sep; 313(7057):583-6. PubMed ID: 8806246
[TBL] [Abstract][Full Text] [Related]
18. Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982-1994.
Page-Shafer K; Veugelers PJ; Moss AR; Strathdee S; Kaldor JM; van Griensven GJ
Am J Epidemiol; 1997 Oct; 146(7):531-42. PubMed ID: 9326430
[TBL] [Abstract][Full Text] [Related]
19. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. SEROCO Study Group.
Carré N; Deveau C; Belanger F; Boufassa F; Persoz A; Jadand C; Rouzioux C; Delfraissy JF; Bucquet D
AIDS; 1994 Jun; 8(6):797-802. PubMed ID: 8086139
[TBL] [Abstract][Full Text] [Related]
20. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe.
Lancet; 2000 Apr; 355(9210):1131-7. PubMed ID: 10791375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
